Clinically Significant Drug Interactions with New Immunosuppressive Agents

被引：0
|
作者：
Christian Mignat
机构：
[1] Christian Albrechts University of Kiel,Department of Pharmacology
来源：
Drug Safety | 1997年 / 16卷
关键词：
Adis International Limited; Tacrolimus; Sirolimus; Mycophenolate Mofetil; Danazol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Tacrolimus (FK506), mycophenolate mofetil, sirolimus (rapamycin), gusperimus, and monoclonal antibody preparations are new immunosuppressive agents, some of which are already approved for clinical use, while others are currently undergoing clinical trials. The present article provides an overview of adverse drug interactions between these immunosuppressants and other drugs which may be used concomitantly.
引用
收藏
页码：267 / 278
页数：11
相关论文
共 50 条
  • [31] Clinically Significant Drug-Drug Interactions Between Oral Anticancer Agents and Nonanticancer Agents: A Delphi Survey of Oncology Pharmacists
    Chan, Alexandre
    Tan, Seow-Hwei
    Wong, Chen May
    Yap, Kevin Yi-Lwern
    Ko, Yu
    CLINICAL THERAPEUTICS, 2009, 31 : 2379 - 2386
  • [32] Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics
    Spina, Edoardo
    Pisani, Francesco
    de Leon, Jose
    PHARMACOLOGICAL RESEARCH, 2016, 106 : 72 - 86
  • [33] A NEW CLINICALLY USEFUL IMMUNOSUPPRESSIVE DRUG, BREDININ
    ISHIKAWA, H
    TSUJINO, M
    MIZUNO, K
    MURASE, J
    HAYANO, K
    WATANABE, T
    ABE, J
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1980, 2 (03): : 219 - 219
  • [34] Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies
    Gatti, Milo
    De Ponti, Fabrizio
    Pea, Federico
    CNS DRUGS, 2021, 35 (04) : 345 - 384
  • [35] Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies
    Milo Gatti
    Fabrizio De Ponti
    Federico Pea
    CNS Drugs, 2021, 35 : 345 - 384
  • [36] Clinically Significant Drug Interactions Associated With HIV Medications
    Sidhpura, Kinjal Vakil
    US PHARMACIST, 2015, 40 (04) : 48 - 56
  • [37] Clinically significant pharmacokinetic drug interactions with carbamazepine - An update
    Spina, E
    Pisani, F
    Perucca, E
    CLINICAL PHARMACOKINETICS, 1996, 31 (03) : 198 - 214
  • [38] CLINICALLY SIGNIFICANT DRUG-INTERACTIONS WITH THE ORAL ANTICOAGULANTS
    FREEDMAN, MD
    OLATIDOYE, AG
    DRUG SAFETY, 1994, 10 (05) : 381 - 394
  • [39] CLINICALLY SIGNIFICANT CARBAMAZEPINE DRUG-INTERACTIONS - AN OVERVIEW
    PIPPENGER, CE
    EPILEPSIA, 1987, 28 : S71 - S76
  • [40] Antidepressant–Drug Interactions are Potentially but Rarely Clinically Significant
    C Lindsay DeVane
    Neuropsychopharmacology, 2006, 31 : 1594 - 1604
12345